[1] FORD J H,NERO D,KIM G,et al.Societal burden of cluster headache in the United States:a descriptive economic analysis[J].J Med Econ,2018,21(1):107-111.
[2] Headache Classification Committee of the International Headache Society (IHS).The International Classification of Headache Disorders,3rd edition[J].Cephalalgia,2018,38(1):1-211.
[3] 孔君,陈陆馗.原发性三叉神经痛微血管减压术后预后影响因素研究的进展[J].东南大学学报(医学版),2016,35(5):821-823.
[4] TFELT-HANSEN P,TFELT-HANSEN J.Verapamil for cluster headache.Clinical pharmacology and possible mode of action[J].Headache,2009,49(1):117-125.
[5] BUSSE D,TEMPLIN S,MIKUS G,et al.Cardiovascular effects of (R)-and (S)-verapamil and racemic verapamil in humans:a placebo-controlled study[J].Eur J Clin Pharmacol,2006,62(8):613-619.
[6] MANSOOR A,MAHABADI N.Volume of distribution[M].Treasure Island:Statpearls Publishing,2020.
[7] LEMMA G L,WANG Z,HAMMAN M A,et al.The effect of short-and long-term administration of verapamil on the disposition of cytochrome P4503A and P-glycoprotein substrates[J].Clin Pharmacol Ther,2006,79(3):218-230.
[8] HOLLAND P,GOADSBY P J.The hypothalamic orexinergic system:pain and primary headaches[J].Headache,2007,47(6):951-962.
[9] MEYER E L,WALDENLIND E,MARCUS C.Diminished nocturnal lipolysis in cluster headache:a sign of central sympathetic dysregulation?[J].Neurology,2003,61(9):1250-1254.
[10] MAY A.Cluster headache:pathogenesis,diagnosis,and management[J].Lancet,2005,366(9488):843-855.
[11] BLAU J N,ENGEL H O.Individualizing treatment with verapamil for cluster headache patients[J].Headache,2004,44(10):1008-1013.
[12] GOADSBY P J.Therapeutic prospects for migraine:can paradise be regained?[J].Ann Neurol,2013,74(3):423-434.
[13] WARFVINGE K,EDVINSSON L.Pearls and pitfalls in neural CGRP immunohistochemistry[J].Cephalalgia,2013,33(8):593-603.
[14] HEWITT D J,AURORA S K,DODICK D W,et al.Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine[J].Cephalalgia,2011,31(6):712-722.
[15] VOLLESEN A L H,SNOER A,BESKE R P,et al.Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks:A Randomized Clinical Trial[J].JAMA Neurol,2018,75(10):1187-1197.
[16] PETERSEN A S,BARLOESE M C J,SNOER A,et al.Verapamil and Cluster Headache:Still a Mystery.A Narrative Review of Efficacy,Mechanisms and Perspectives[J].Headache,2019,59(8):1198-1211.
[17] DODICK D W,GOADSBY P J,SPIERINGS E L,et al.Safety and efficacy of LY2951742,a monoclonal antibody to calcitonin gene-related peptide,for the prevention of migraine:a phase 2,randomised,double-blind,placebo-controlled study[J].Lancet Neurol,2014,13(9):885-892.
[18] TFELT-HANSEN P,OLESEN J.Possible site of action of CGRP antagonists in migraine[J].Cephalalgia,2011,31(6):748-750.
[19] MARCUS R,GOADSBY P J,DODICK D,et al.BMS-927711 for the acute treatment of migraine:a double-blind,randomized,placebo controlled,dose-ranging trial[J].Cephalalgia,2014,34(2):114-125.
[20] LEROUX E,DUCROS A.Cluster headache[J].Orphanet Journal of Rare Diseases,2008,3(2):20-28.
[21] KO E A,PARK W S,SON Y K,et al.Calcium channel inhibitor,verapamil,inhibits the voltage-dependent K+ channels in rabbit coronary smooth muscle cells[J].Biol Pharm Bull,2010,33(1):47-52.
[22] OLESEN J.The role of nitric oxide (NO) in migraine,tension-type headache and cluster headache[J].Pharmacol Ther,2008,120(2):157-171.
[23] 李文刚,吴冬寒,符亮,等.双歧杆菌三联活菌肠溶胶囊对NAFLD患者的疗效及血清NO、内毒素、RBP4的影响[J].东南大学学报(医学版),2018,37(1):96-100.
[24] SANCES G,TASSORELLI C,PUCCI E,et al.Reliability of the nitroglycerin provocative test in the diagnosis of neurovascular headaches[J].Cephalalgia,2004,24(2):110-119.
[25] COSTA A,RAVAGLIA S,SANCES G,et al.Nitric oxide pathway and response to nitroglycerin in cluster headache patients:plasma nitrite and citrulline levels[J].Cephalalgia,2003,23(6):407-413.
[26] STEINBERG A,WIKLUND N P,BRUNDIN L,et al.Levels of nitric oxide metabolites in cerebrospinal fluid in cluster headache[J].Cephalalgia,2010,30(6):696-702.
[27] REJDAK K,EIKELENBOOM M J,PETZOLD A,et al.CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis[J].Neurology,2004,63(8):1439-1445.
[28] ROBBINS M S,STARLING A J,PRINGSHEIM T M,et al.Treatment of Cluster Headache:The American Headache Society Evidence-Based Guidelines[J].Headache,2016,56(7):1093-1106.
[29] STEINBERG A,FOURIER C,RAN C,et al.Cluster headache-clinical pattern and a new severity scale in a Swedish cohort[J].Cephalalgia,2018,38(7):1286-1295.
[30] RAN C,FOURIER C,ARAFA D,et al.Anoctamin 3:A Possible Link between Cluster Headache and Ca(2+) Signaling[J].Brain Sciences,2019,9(8):12-15. |
